Some fundamental drivers such as market cap or Dicerna Pharmaceuticals enterprice value can be analyzed from historical prospective to project value of the company into the future. Some investors analyze Dicerna Pharmaceuticals valuation indicators such as Enterprise Value of 650 M or Invested Capital of 37.1 M to time the market or to short-sell their positions based on the trend in valuation ratios. It is a perfect tool to project the direction of Dicerna Pharmaceuticals future value. Financial Statement Analysis is much more than just reviewing and breaking down Dicerna Pharmaceuticals prevalent accounting reports in order to predict its past. Macroaxis encourages investors to analyze financial statement over time for various trends across multiple indicators and accounts to determine whether Dicerna Pharmaceuticals is a good buy for the upcoming year. Additionally see Investing Opportunities.
Enterprise ValueEnterprise Value (or EV) is usually referred to as Dicerna Pharmaceuticals theoretical takeover price. In the event of an acquisition, an acquirer would have to take on Dicerna Pharmaceuticals debt, but would also pocket its cash. Enterprise Value is more accurate representation of Dicerna Pharmaceuticals value than its market capitalization because it takes into account all of Dicerna Pharmaceuticals existing debt. Enterprise value is a measure of the value of a business as a whole; calculated as [MarketCap] plus [DebtUSD] minus [CashnEqUSD].
Invested CapitalInvested capital represents the total cash investment that shareholders and debt holders have contributed to Dicerna Pharmaceuticals. There are two different methods for calculating Dicerna Pharmaceuticals invested capital: operating approach and financing approach. Understanding ##company1# invested capital allows investors to calculate measures of performance such as return on invested capital or return on capital employed. Invested capital is an input into the calculation of Return on Invested Capital; and is calculated as: [Debt] plus [Assets] minus [Intangibles] minus [CashnEq] minus [LiabilitiesC]. Please note this calculation method is subject to change.
Market CapitalizationMarket capitalization (or market cap) is the total value of the shares outstanding of Dicerna Pharmaceuticals. It is equal to Dicerna Pharmaceuticals current share price times the number of Dicerna Pharmaceuticals outstanding shares. Represents the product of [SharesBas]; [Price] and [ShareFactor].